Citeline Podcasts
Episodes
Trends In Epidemiology
23 Nov 2023
Contributed by Lukas
Datamonitor Healthcare’s Epidemiology team (Ridwaan Ibrahim, Lucia Rodriguez-Garcia, Maya Trivedy, and Asma Ali) discuss the current trends in epide...
Scrip Lifetime Achievement Award 2023: Jeremy Levin’s Acceptance Speech
22 Nov 2023
Contributed by Lukas
In accepting Scrip’s Lifetime Achievement Award, Ovid Therapeutics’ CEO called on pharma to show responsible leadership and live up to its potenti...
China Biotech Podcast (Chinese language) - November 2023
21 Nov 2023
Contributed by Lukas
Brian Yang and Dexter Yan discuss the FDA approval of Chinese PD-1, Sanofi BioMap AI deal, Third quarter earnings and Biden-Xi Summit and US-China reg...
Discussing The Potentials Of And Challenges For Digital Therapeutics
21 Nov 2023
Contributed by Lukas
In this podcast, Medtech Insight speaks to Andy Molnar, CEO of the digital therapeutics alliance; Joel Morse, CEO and co-founder of Curavit and Owen M...
Digital Health Roundup: Black Friday Hits – Digital Twins, Biowearables, Robotics, Cardiology
21 Nov 2023
Contributed by Lukas
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights interviews with Abbott’s head of Lingo Biowearables and top exe...
Scrip’s Five Must-Know Things – 20 November 2023
20 Nov 2023
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: AstraZeneca CEO on obesity and more; bio...
Drug Fix: Janet Woodcock retiring, Accelerated Approval Reform, US FDA Meeting Recording Policy
17 Nov 2023
Contributed by Lukas
Pink Sheet reporters and editors discuss US FDA Principal Deputy Commissioner Janet Woodcock’s legacy as her retirement approaches (:42), the stance...
Syngene CEO On Sub-Dynamics As US Biotech Funding Finds New Normal, ADC Capabilities
17 Nov 2023
Contributed by Lukas
Syngene’s MD & CEO, Jonathan Hunt, in an interview with Scrip, dissects trends and opportunities in the CRDMO segment as US biotechs slow their burn...
Scrip’s Five Must-Know Things – 13 November 2023
13 Nov 2023
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: US approval for Lilly’s obesity drug; ...
Drug Fix: FTC Orange Book Patent Challenges, Ad/Promo Due Diligence, US FDA Adcomm Decision Appeal
10 Nov 2023
Contributed by Lukas
Pink Sheet reporter and editors discuss the FTC’s challenges of Orange Book patents (:35), DTC promotion practices as part of acquisition due dilige...
How OTC Companies Can Respond To Preventative Health Trends - With Simon Kucher & Partners
10 Nov 2023
Contributed by Lukas
In this episode, HBW Insight speaks to Simon-Kucher & Partners about the latest trends in preventative consumer health. Partner Christian Rebholz and ...
Humira Biosimilar Landscape Podcast
08 Nov 2023
Contributed by Lukas
Humira Biosimilar Landscape Other platforms Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836 Goog...
일본 최대 바이오클러스터, 한국 바이오벤처들과 CGT 협업 추진 (Korean-language podcast)
07 Nov 2023
Contributed by Lukas
일본 최대 제약바이오 R&D 허브와 한국 바이오벤처들이 세포유전자치료제 분야의 협업을 활발히 추진하고 있다는...
Scrip’s Five Must-Know Things – 6 November 2023
06 Nov 2023
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: CEOs on global tensions; Roche’s new A...
Drug Fix: CMS Listens On Price Negotiations, Elevidys Top-Line Trial Data, Gene Therapy Reg Changes
03 Nov 2023
Contributed by Lukas
Pink Sheet reporters and editor discuss take-aways from the first Medicare price negotiation program public listening sessions (:35), next steps after...
【3分で解説 世界のファーマ】第14回 承認２カ月後に新薬発売へ、スイスの新制度 (Japanese-language podcast)
02 Nov 2023
Contributed by Lukas
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...
Podcast: Overcoming regulatory challenges in a complex clinical trial landscape
01 Nov 2023
Contributed by Lukas
Listen in as Citeline sits down with a regulatory and compliance expert Mai Mishir, Senior Director, Global Regulatory Affairs from Advanced Clinical....
Biotech CEO Podcast with William Wei Cao of Gracell Bio
01 Nov 2023
Contributed by Lukas
Brian Yang interviews Nasdaq-listed cell therapy developer Gracell Bio Founder and CEO William Wei Cao who discussed the plan to enter the US market t...
China Biotech Podcast (Chinese language) - October 2023
31 Oct 2023
Contributed by Lukas
In this Chinese-language podcast, Brian Yang and Dexter Yan discuss China biotech topics including the annual IND and NDA report from Center for Drug ...
Scrip’s Five Must-Know Things – 30 October 2023
30 Oct 2023
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: did Pfizer miss out on Roivant/Roche dea...
Drug Fix: Off-Label Coms Guidance, Price Negotiations And Prescribing, Bertagnolli’s NIH Bid
27 Oct 2023
Contributed by Lukas
Pink Sheet reporters and editors discuss new off-label use communications guidance (:35), how price negotiations could impact prescribing (9:49), and ...
AI In Behavioral Health Clinics
25 Oct 2023
Contributed by Lukas
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights interviews with behavioral health experts on implementing AI solu...
Over The Counter 24 Oct 2023: An Approach To MoCRA With Good Face Project’s Iva Teixeira
24 Oct 2023
Contributed by Lukas
Over The Counter 24 Oct 2023: An Approach To MoCRA With Good Face Project’s Iva Teixeira by Citeline
Scrip’s Five Must-Know Things – 23 October 2023
23 Oct 2023
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Daiichi’s huge ADC deal with Merck; mi...
Drug Fix: BrainStorm Withdraws NurOwn, NIH Nominee On Drug Pricing, Gene Therapy Long-Term Follow-Up
20 Oct 2023
Contributed by Lukas
Pink Sheet reporters and editor discuss BrainStorm’s next steps after withdrawing the NurOwn BLA (:38), NIH director nominee Monica Bertagnolli’s ...
Medtech Insight: The Realities Of Real-World Evidence.
18 Oct 2023
Contributed by Lukas
n this special podcast, Medtech Insight managing editor Elizabeth Orr talks to consultant Steve Silverman about the FDA’s current position on real-w...
Q&A with Dr. Marc Sandberg: A Specialist in Endocrinology, Diabetes & Metabolism
18 Oct 2023
Contributed by Lukas
Q&A with Dr. Marc Sandberg: A Specialist in Endocrinology, Diabetes & Metabolism by Citeline
Centrient Delivers Innovation In Biotechnology
17 Oct 2023
Contributed by Lukas
Listen as executives from Centrient Pharmaceuticals share insider perspectives on innovations in sustainable, efficient, clean manufacturing practices...
Q&A with Sleep Medicine Specialist Nathaniel Watson, MD
16 Oct 2023
Contributed by Lukas
Q&A with Sleep Medicine Specialist Nathaniel Watson, MD by Citeline
Scrip’s Five Must-Know Things – 16 October 2023
16 Oct 2023
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: BMS buys Mirati; slow Q3 for biopharma M...
Drug Fix: US FDA Suffers From Shutdown Threat, Alnylam’s CR Letter, ARPA-H Wants FDA Incentives
13 Oct 2023
Contributed by Lukas
Pink Sheet reporters and editor discuss the problems that emerged for the US FDA from just the threat of a government shutdown (:38), take-aways on th...
Scrip’s Five Must-Know Things – 11 October 2023
11 Oct 2023
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Lilly’s radiopharmaceutical buy; stron...
아일랜드, 글로벌 제약사의 투자처로 각광 (Korean-language podcast)
09 Oct 2023
Contributed by Lukas
릴리, 다케다, 아스트라제네카에 이어 MSD, 아스텔라스도 아일랜드에 대규모 투자 동참 https://scrip.citeline.com/SC14904...
What’s Going On With Oral Phenylephrine In The US? With HBW’s Malcolm Spicer
06 Oct 2023
Contributed by Lukas
In this episode, HBW Insight speaks to its own OTC expert, managing editor Malcom Spicer, about recent controversy in the US surrounding oral nasal de...
Medtech Connect Episode 10: Breaking Down The Transitional Coverage Of Emerging Technologies
04 Oct 2023
Contributed by Lukas
In this episode, Medtech Insight regulatory reporter Hannah Daniel speaks to Washington Analysis vice president and senior healthcare analyst John Lep...
Scrip’s Five Must-Know Things – 3 October 2023
03 Oct 2023
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: major Q4 catalysts; Verona’s COPD cont...
Scrip M&A Podcast: US FTC Review of Mergers and Acquisitions
02 Oct 2023
Contributed by Lukas
Scrip writers Joseph Haas and Jessica Merrill discuss US FTC overview of biopharma mergers like Amgen/Horizon and Pfizer/Seagen with Leerink Partners'...
Drug Fix: Adcomm Rejects NurOwn For ALS, FDA In Shutdown Mode, Limited Price Negotiation Savings
29 Sep 2023
Contributed by Lukas
Pink Sheet reporters and editors consider the fallout from Brainstorm Cell Therapeutics Inc.’s negative US FDA advisory committee decision on its AL...
Scrip’s Five Must-Know Things – 28 September 2023
28 Sep 2023
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Novartis gives back Beigene PD-1; BMS re...
Disrupting the Consumer Health Industry, With Maxwellia’s Anna Maxwell
25 Sep 2023
Contributed by Lukas
In this episode, HBW Insight catches up with UK switch specialists Maxwellia to find out what’s next for the company that gave to the UK one of the ...
Insitro’s Daphne Koller On The Marriage Of Biology And Machine Learning At The Company’s Heart
25 Sep 2023
Contributed by Lukas
Industry veteran and serial entrepreneur Daphne Koller tells In Vivo about how her company, Insitro, is unleashing the potential of computational biol...
Scrip’s Five Must-Know Things – 20 September 2023
20 Sep 2023
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Biomarin’s next chapter; Amgen’s obe...
Drug Fix: Regeneron’s COVID Monoclonal Deal, New FDA Advisor, Project Optimus In Cancer Combos
15 Sep 2023
Contributed by Lukas
Pink Sheet reporter and editors discuss the somewhat novel pricing language in Regeneron’s deal with the US government to develop a COVID-19 monoclo...
Scrip’s Five Must-Know Things – 13 September 2023
13 Sep 2023
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: the rise of Novo Nordisk; senior level c...
Trends Shaping The OTC Industry Today, With BSS Consulting’s Birgit Schuhbauer
11 Sep 2023
Contributed by Lukas
In the second part of HBW Insight’s exclusive interview with OTC industry veteran Birgit Schuhbauer, we discuss the trends that will shape the futur...
지피지기면 백전백승” 대웅이노베이션의 미국시장 전략 (Korean-language podcast)
11 Sep 2023
Contributed by Lukas
어동규 대웅이노베이션홀딩스 대표의 Scrip Intelligence 인터뷰 기사를 요약한 내용입니다 https://scrip.citeline.com/SC1487...
Drug Fix: FTC Ends Amgen-Horizon Case, New Ultra-Rare Cancer Partnership, Generic Applications Lag
08 Sep 2023
Contributed by Lukas
Pink Sheet reporter and editors discuss the US Federal Trade Commission ending its attempt to block the Amgen acquisition of Horizon Therapeutics (:28...
Medtech Connect Episode 9: The Intersection Of IVDs And Digital Health
07 Sep 2023
Contributed by Lukas
In this episode, Medtech Insight regulatory reporter Hannah Daniel and managing editor Amanda Maxwell speak to Marcel Gehrung, co-founder and CEO of C...
Dr Reddy’s MD On The Next Horizon, Owner-Managed Firms, Life Lessons From Birds
07 Sep 2023
Contributed by Lukas
Dr Reddy's Laboratories' co-chairman and managing director, G V Prasad, talks with Scrip’s Anju Ghangurde about his conversations with late founder ...
Creating A Digital Biotech Story
06 Sep 2023
Contributed by Lukas
In this latest instalment of the In Vivo podcast Daniel Lofaso, CEO of Digital Elevator, talks about the common mistakes biotech companies make when t...
Scrip’s Five Must-Know Things – 4 September 2023
04 Sep 2023
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: US Medicare price negotiations get soft ...
Digital Health Roundup: VR, AI Trends In Rehabilitation; Cybersecurity Regulations; Medicare Updates
01 Sep 2023
Contributed by Lukas
Summary: In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights VR, AI and other high tech trends in rehabilitation and...
Drug Fix: What We Learned From The First Medicare Price Negotiation List, Pepaxto Withdrawal Update
01 Sep 2023
Contributed by Lukas
Pink Sheet reporters and editors consider lessons and next steps after the first list of drugs subject to Medicare price negotiations was released (:3...
China Biotech CEO Interview with Hua Medicine’s Li Chen
01 Sep 2023
Contributed by Lukas
Hua Medicine’s founder and CEO Li Chen discusses with host Brian Yang about its new product launch for dorzagliatin, glucokinase activator for type ...
Emergex CEO Questions mRNA Vaccines Against ‘Wuhan Virus’, Works On Universal Vaccines
31 Aug 2023
Contributed by Lukas
Scrip’s senior editor Vibha Ravi speaks with Dr Thomas Rademacher, Emergex CEO and ex-research director at the University of Oxford, about the myth ...
Podcast: Operationalizing Decentralized Clinical Trials
30 Aug 2023
Contributed by Lukas
Listen in as experts from Advanced Clinical discuss the evolution of the decentralized clinical trial model and what it means in a post-COVID landscap...
How To Be A Consumer Health Leader, With BSS Consulting’s Birgit Schuhbauer
29 Aug 2023
Contributed by Lukas
In this episode, HBW Insight talks to BSS Consulting’s Birgit Schuhbauer about her stellar career in consumer healthcare. Up until recently, Schuhba...
Fourth Time Lucky: How Mithra’s Novel Estrogen E4 Is Disrupting The Women’s Health Market
29 Aug 2023
Contributed by Lukas
Mithra is shaking up the stagnant women’s health market with a brand new estrogenic compound. E4, or estetrol, is a natural estrogen produced by the...
Scrip’s Five Must-Know Things – 28 August 2023
28 Aug 2023
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Roche’s TIGIT data leak; Regeneron get...
China Biotech Podcast - August 2023 (Chinese-language)
24 Aug 2023
Contributed by Lukas
In this Chinese-language podcast, Brian Yang and Dexter Yan discuss the latest hot topics in August in China’s biotech sector, which include a massi...
Scrip’s Five Must-Know Things – 21 August 2023
21 Aug 2023
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: a look at global executive compensation;...
Drug Fix: Medicare Price Negotiation List Preview, Mifepristone Ruling, AZ Sales Aid Warning Letter
18 Aug 2023
Contributed by Lukas
Pink Sheet reporters and editor discuss a projected list of drugs that could be eligible for the first round of Medicare price negotiations (:40), the...
UK OTC Marketing Awards Judge On What Makes A Standout Entry, With PAGB's Michelle Riddalls
14 Aug 2023
Contributed by Lukas
In this special episode, we speak to PAGB CEO Michelle Riddalls about being a UK OTC Marketing Awards judge and what makes a good entry in her extensi...
Scrip’s Five Must-Know Things – 14 August 2023
14 Aug 2023
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Wegovy’s solid new trial results; Lill...
Drug Fix: Wegovy’s CV Benefits, Mifepristone And Water Contamination, US FDA Back To The Office?
11 Aug 2023
Contributed by Lukas
Pink Sheet reporters and editors discuss the impact of a study showing cardiovascular benefits for the weight loss drug Wegovy (:45), another attempt ...
【3分で解説 世界のファーマ】第13回 薬価めぐり違憲訴訟へ 米国、インフレ抑制法 (Japanese-language podcast)
09 Aug 2023
Contributed by Lukas
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で...
What Happens To Software As A Medical Device Under The EU AI Act? With Bristows’ Jamie Hatzel
07 Aug 2023
Contributed by Lukas
In the second part of HBW Insight’s chat with Bristows digital health regulatory expert Jamie Hatzel, we talk about artificial intelligence. Specifi...
Scrip’s Five Must-Know Things – 31 July 2023
07 Aug 2023
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the past business week. https://scrip.pharmaintelligence.informa.com/SC148825/Qu...
Drug Fix Special: Assessing US FDA Advisory Committee Reform Proposals
04 Aug 2023
Contributed by Lukas
Pink Sheet reporters and editors and special guests from 3D Communications, a firm that helps sponsors prepare for advisory committee meetings, dig in...
How The Eudamed Medical Device Database Is Progressing Slowly But Surely And the Challenges Ahead
04 Aug 2023
Contributed by Lukas
How The Eudamed Medical Device Database Is Progressing Slowly But Surely And the Challenges Ahead
일본 항암제, CNS 치료제, 미국시장서 높은 허가가능성 보여 (Korean-language podcast)
03 Aug 2023
Contributed by Lukas
Citeline의 최신 연구보고서에 따르면 미국시장에서 대형 일본제약사들의 항암제, CNS 치료제 허가가능성이 상대적으...
Medtech Connect Episode 8: Exploring Regulatory Differences In The EU And US
03 Aug 2023
Contributed by Lukas
In this episode of Medtech Connect, EU Senior Reporter Eliza Slawther and US Reporter Hannah Daniel explore the similarities and differences between E...
Scrip’s Five Must-Know Things – 31 July 2023
31 Jul 2023
Contributed by Lukas
Audio roundup of selected biopharma industry content from Scrip over the past business week. Links to discussed stories at the link below: https://sc...
CEO Of Cell Therapy Firm Stempeutics Talks Partnerships In Japan, Changes In India Trials Regulation
28 Jul 2023
Contributed by Lukas
Scrip’s Mumbai-based senior editor Vibha Ravi speaks with Dr B N Manohar, CEO of Indian cell and gene therapy firm Stempeutics Research. The company...
China Biotech Podcast - July 2023 (Chinese language)
28 Jul 2023
Contributed by Lukas
Brian Yang, Dexter Yan and guest Jin Wang discuss trending biotech topics including recent antibody deals, China biotech innovation and underlying dri...
Digital Health Roundup: What’s Hot On Investment; Diabetes; AI
27 Jul 2023
Contributed by Lukas
In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb looks back at ADA 2023 highlights and her interviews with diabetes company e...
A Digital Marketplace Aims To Make Asset Acquisition Frictionless
27 Jul 2023
Contributed by Lukas
9xchange CEO Anat Naschitz and Benevolent AI's Matthew Fujisawa spoke with In Vivo about how they are trying to make selling and buying pharma assets ...